לוקרין פ.ד.ס דפו 3.75 מ"ג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate 3.75 mg/vial - suspension for injection - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
לוקרין פ.ד.ס דפו 11.25 מ"ג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate 11.25 mg - powder for suspension for injection - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
לוקרין פ.ד.ס דפו 11.25 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin
לוקרין פ.ד.ס דפו 11.25 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin
לוקרין פ.ד.ס דפו 3.75 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 3.75 mg - leuprorelin
לוקרין פ.ד.ס דפו 3.75 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 3.75 mg - leuprorelin